Angela C. Kothe

Angela C. Kothe is Vice President of Silver Pharma Consulting, Inc., a firm providing clinical development, medical safety, and regulatory consulting expertise to a variety of domestic and international ophthalmology clients. Angela brings 25 years of experience in the pharmaceutical, biotechnology, and medical device industry. Prior to consulting, Angela spent 19 years at Alcon Laboratories, Inc. She began her pharmaceutical career in 1993 managing clinical trials at Alcon, and in 2000, transitioned to regulatory affairs at Alcon. Her leadership in regulatory affairs led to the approval of key anti-infective, anti-inflammatory, ocular allergy, and glaucoma products in the US and internationally. During the past five years, she has provided regulatory expertise to ophthalmic companies in the areas of ocular allergy, glaucoma, inflammation, retina, and dry eye. She has led several companies through the IND and NDA process, provided regulatory strategies and managed operational activities, and led meetings with the FDA and international health agencies.

Angela holds a Bachelor of Science (Life Sciences) from Queen’s University, Kingston, Ontario, Canada, and a Doctor of Optometry and a Ph.D. in visual electrophysiology from the University of Waterloo, Ontario, Canada.